Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia

To report on the treatment of long-standing sympathetic ophthalmia by intravitreal triamcinolone acetonide.Clinical interventional case report.A 47-year-old patient who suffered from sympathetic ophthalmia and who was treated with intensive systemic immunosuppressive therapy received an intravitreal injection of 25 mg of triamcinolone acetonide. Before injection, intraocular pressure ranged between 5 and 8 mm Hg; visual acuity measured...